Office for State, Tribal, Local and Territorial Support (OSTLTS), 75923-75924 [2013-29746]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29745 Filed 12–12–13; 8:45 am]
[FR Doc. 2013–29750 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
ehiers on DSK2VPTVN1PROD with NOTICES
Prevention and the Agency for Toxic
Substances and Disease Registry.
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
The meeting announced below
concerns Clinical, Epidemiologic and
Ecologic Factors Impacting the Burden
and Distribution of Monkeypox in
Tshuapa District, Democratic Republic
of the Congo, Funding Opportunity
Announcement (FOA) CK14–002, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time And Date: 1:00 p.m.–3:00 p.m.,
February 18, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Clinical, Epidemiologic and Ecologic
Factors Impacting the Burden and
Distribution of Monkeypox in Tshuapa
District, Democratic Republic of the
Congo, FOA CK14–002’’.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
VerDate Mar<15>2010
13:32 Dec 12, 2013
Jkt 232001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 9:00 a.m.–3:00 p.m.
EST, January 9, 2014.
Place: The meeting will be held via
Teleconference.
Limited teleconference access is also
available. Teleconference login
information is as follows:
For Public:
TOLL–FREE PHONE #: 888–989–8135
Participant passcode: BREASTCANCER
or 273278226237
For Public:
Net Conference URL: https://www.my
meetings.com/nc/join/
Conference number: PW3233834
Audience passcode: BREASTCANCER
or
Public can join the event directly at:
https://www.mymeetings.com/nc/join.
php?i=PW3233834&p=BREAST
CANCER&t=c.
There is also a toll free number for
anyone outside of the USA: TOLL #: 1–
203–827–7034.
Participant passcode:
BREASTCANCER or 273278226237.
Status: Open to the public, limited
only by the net conference and audio
phone lines available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
75923
dissemination of credible appropriate
messages and resource materials.
Matters To Be Discussed: The agenda
will include discussions on the current
and emerging topics related to breast
cancer in young women. These may
include risk communication and health
education, as well as approaches to
increase awareness of clinicians/
practitioners regarding topics such as
breast cancer risk, breast health,
symptoms, diagnosis, and treatment of
breast cancer in young women.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: All
ACBCYW Meeting participants must
register for the meeting online at least 5
days in advance at https://www.cdc.gov/
cancer/breast/what_cdc_is_doing/
meetings.htm. Please complete all the
required fields before submitting your
registration and submit no later than
January 5, 2014.
Contact Person For More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE., Mailstop K52, Atlanta, Georgia
30341, Telephone (770) 488–4518, Fax
(770) 488–4760 Email: acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29749 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Office for State, Tribal, Local and
Territorial Support (OSTLTS)
In accordance with Presidential
Executive Order No. 13175, November
6, 2000, and the Presidential
Memorandum of November 5, 2009, and
September 23, 2004, Consultation and
Coordination with Indian Tribal
Governments, CDC/Agency for Toxic
Substances and Disease Registry
(ATSDR), announces the following
meeting and Tribal Consultation
Session:
E:\FR\FM\13DEN1.SGM
13DEN1
ehiers on DSK2VPTVN1PROD with NOTICES
75924
Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices
Name: Tribal Advisory Committee (TAC)
Meeting and 10th Biannual Tribal
Consultation Session
Times and Dates: 8:00 a.m.–5:00 p.m.,
February 18, 2014 (TAC Meeting); 8:00 a.m.–
5:00 p.m., February 19, 2014 (10th Biannual
Tribal Consultation Session).
Place: The TAC Meeting and Tribal
Consultation Session will be held at CDC
Headquarters, 1600 Clifton Road NE., Global
Communications Center, Auditorium B3,
Atlanta, Georgia 30333.
Status: The meetings are being hosted by
CDC/ATSDR and are open to the public.
Purpose: In 2011–2012, CDC began revising
its existing Tribal Consultation Policy (issued
in 2005) with the primary purpose of
providing guidance across the agency to work
effectively with American Indian/Alaska
Native (AI/AN) tribes, communities, and
organizations to enhance AI/AN access to
CDC resources and programs. Within the
CDC Consultation Policy, it is stated that
CDC will conduct government-to-government
consultation with elected tribal officials or
their authorized representatives before taking
actions and/or making decisions that affect
them. Consultation is an enhanced form of
communication that emphasizes trust,
respect, and shared responsibility. It is an
open and free exchange of information and
opinion among parties that leads to mutual
understanding and comprehension. CDC
believes that consultation is integral to a
deliberative process that results in effective
collaboration and informed decision making
with the ultimate goal of reaching consensus
on issues. Although formal responsibility for
the agency’s overall government-togovernment consultation activities rests
within the CDC Office of the Director (OD),
other CDC Center, Institute, and Office (CIO)
leadership shall actively participate in TAC
meetings and HHS-sponsored regional and
national tribal consultation sessions as
frequently as possible.
Matters To Be Discussed: The TAC and
CDC leaders will discuss the following public
health issue topics identified by tribal
leaders: Native specimens, behavioral risk
factors, and disease-specific topics; however,
discussion is not limited to these topics.
During the 10th Biannual Tribal
Consultation Session, tribes and CDC leaders
will engage in a listening session with CDC’s
director and roundtable discussions with
CDC senior leadership, and tribes will have
an opportunity to present testimony on tribal
health issues.
Tribal Leaders are encouraged to submit
written testimony by 12:00 a.m., EST on
January 24, 2014, to April R. Taylor, Public
Health Analyst for the Tribal Support Unit,
or CAPT Craig Wilkins, Acting Director for
the Tribal Support Unit, CDC/OSTLTS, via
mail to 4770 Buford Highway NE., MS E–70,
Atlanta, Georgia 30341 or email to
tribalsupport@cdc.gov. Depending on the
time available, it may be necessary to limit
the time of each presenter.
The agenda is subject to change as
priorities dictate.
Information about the TAC, CDC’s Tribal
Consultation Policy, and previous meetings
may be referenced on the following web link:
https://www.cdc.gov/tribal.
VerDate Mar<15>2010
13:32 Dec 12, 2013
Jkt 232001
Contact Person For More Information:
April R. Taylor, Public Health Analyst, CDC/
OSTLTS, via mail to 4770 Buford Highway
NE., MS E–70, Atlanta, Georgia 30341 or
email to ARTaylor@cdc.gov.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29746 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Mine
Safety and Health Research Advisory
Committee (MSHRAC), National
Institute for Occupational Safety and
Health, Centers for Disease Control
and Prevention (CDC), Department of
Health and Human Services (HHS)
The CDC is soliciting nominations for
possible membership on the Mine
Safety and Health Research Advisory
Committee (MSHRAC), National
Institute for Occupational Safety and
Health (NIOSH).
CDC provides subject-matter expertise
and assistance for domestic and global
surveillance, laboratory, occupational
health and epidemiology functions, and
health threats including anthrax,
smallpox, influenza and other infectious
diseases, food-borne illness, and
radiation, among others.
The MSHRAC consists of 13 experts
in fields related to mining safety and
health. The members are selected by the
Secretary, HHS. The committee advises
the NIOSH Director on mining safety
and health research and prevention
programs. The committee also provides
advice on standards of scientific
excellence, current needs in the field of
mining safety and health, and the
applicability and dissemination of
research findings. This advice may take
the form of reports or verbal
communications to the NIOSH Director
during MSHRAC meetings.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the committee’s
mission.
PO 00000
Frm 00015
Fmt 4703
Sfmt 9990
Nominees will be selected based on
expertise in the field of mining safety
and health, such as mining engineering,
industrial hygiene, occupational safety
and health engineering, chemistry,
safety and health education,
ergonomics, epidemiology, statistics,
and psychology.
Federal employees will not be
considered for membership. Members
may be invited to serve for terms of up
to four years. The U.S. Department of
Health and Human Services policy
stipulates that committee membership
shall be balanced in terms of
professional training and background,
points of view represented, and the
committee’s function. In addition to a
broad range of expertise, consideration
is given to a broad representation of
geographic areas within the U.S., with
diverse representation of both genders,
ethnic and racial minorities, and
persons with disabilities. Nominees
must be U.S. citizens, and cannot be
full-time employees of the U.S.
Government.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, email address)
• A letter of recommendation stating
the qualifications of the candidate.
Nomination materials must be
postmarked by January 31, 2014, and
sent to: Jeffery L. Kohler, Ph.D.,
Executive Secretary, MSHRAC, NIOSH,
CDC, 626 Cochrans Mill Road, P.O. Box
18070, Pittsburgh, Pennsylvania 15236,
telephone (412) 386–5301.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29747 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 78, Number 240 (Friday, December 13, 2013)]
[Notices]
[Pages 75923-75924]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29746]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Office for State, Tribal, Local and Territorial Support (OSTLTS)
In accordance with Presidential Executive Order No. 13175, November
6, 2000, and the Presidential Memorandum of November 5, 2009, and
September 23, 2004, Consultation and Coordination with Indian Tribal
Governments, CDC/Agency for Toxic Substances and Disease Registry
(ATSDR), announces the following meeting and Tribal Consultation
Session:
[[Page 75924]]
Name: Tribal Advisory Committee (TAC) Meeting and 10th Biannual
Tribal Consultation Session
Times and Dates: 8:00 a.m.-5:00 p.m., February 18, 2014 (TAC
Meeting); 8:00 a.m.-5:00 p.m., February 19, 2014 (10th Biannual
Tribal Consultation Session).
Place: The TAC Meeting and Tribal Consultation Session will be
held at CDC Headquarters, 1600 Clifton Road NE., Global
Communications Center, Auditorium B3, Atlanta, Georgia 30333.
Status: The meetings are being hosted by CDC/ATSDR and are open
to the public.
Purpose: In 2011-2012, CDC began revising its existing Tribal
Consultation Policy (issued in 2005) with the primary purpose of
providing guidance across the agency to work effectively with
American Indian/Alaska Native (AI/AN) tribes, communities, and
organizations to enhance AI/AN access to CDC resources and programs.
Within the CDC Consultation Policy, it is stated that CDC will
conduct government-to-government consultation with elected tribal
officials or their authorized representatives before taking actions
and/or making decisions that affect them. Consultation is an
enhanced form of communication that emphasizes trust, respect, and
shared responsibility. It is an open and free exchange of
information and opinion among parties that leads to mutual
understanding and comprehension. CDC believes that consultation is
integral to a deliberative process that results in effective
collaboration and informed decision making with the ultimate goal of
reaching consensus on issues. Although formal responsibility for the
agency's overall government-to-government consultation activities
rests within the CDC Office of the Director (OD), other CDC Center,
Institute, and Office (CIO) leadership shall actively participate in
TAC meetings and HHS-sponsored regional and national tribal
consultation sessions as frequently as possible.
Matters To Be Discussed: The TAC and CDC leaders will discuss
the following public health issue topics identified by tribal
leaders: Native specimens, behavioral risk factors, and disease-
specific topics; however, discussion is not limited to these topics.
During the 10th Biannual Tribal Consultation Session, tribes and
CDC leaders will engage in a listening session with CDC's director
and roundtable discussions with CDC senior leadership, and tribes
will have an opportunity to present testimony on tribal health
issues.
Tribal Leaders are encouraged to submit written testimony by
12:00 a.m., EST on January 24, 2014, to April R. Taylor, Public
Health Analyst for the Tribal Support Unit, or CAPT Craig Wilkins,
Acting Director for the Tribal Support Unit, CDC/OSTLTS, via mail to
4770 Buford Highway NE., MS E-70, Atlanta, Georgia 30341 or email to
tribalsupport@cdc.gov. Depending on the time available, it may be
necessary to limit the time of each presenter.
The agenda is subject to change as priorities dictate.
Information about the TAC, CDC's Tribal Consultation Policy, and
previous meetings may be referenced on the following web link:
https://www.cdc.gov/tribal.
Contact Person For More Information: April R. Taylor, Public
Health Analyst, CDC/OSTLTS, via mail to 4770 Buford Highway NE., MS
E-70, Atlanta, Georgia 30341 or email to ARTaylor@cdc.gov.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-29746 Filed 12-12-13; 8:45 am]
BILLING CODE 4163-18-P
